The Diagnostic Value of Dual-source CT in Adult Atrial Septal Defect with Pulmonary Hypertension
-
摘要:
目的:探讨双源CT评价成人房间隔缺损(ASD)合并肺动脉高压(PAH)的诊断价值。方法:回顾性分析我院75例成人ASD患者,根据右心导管(RHC)检查术所得肺动脉平均压(mPAP)是否≥25 mmHg分为PAH组(40例)和无PAH组(35例)。所有患者均在术前1周内行DSCT先天性心脏病检查,测量升主动脉直径(AAD)、主肺动脉直径(MPAD)、右肺动脉干直径(RPAD)、左肺动脉干直径(LPAD)、右下肺动脉直径(RLPAD)、双心室短轴最大内径(RVD、LVD)、脊柱室间隔夹角、ASD直径,计算MPAD与AAD比值(rPA)、RVD与LVD比值(RVD/LVD)。采用t检验评价两组患者临床资料、RHC检查指标、CT心血管参数差异;使用ROC曲线确定双源CT对成人ASD合并PAH的诊断效能;使用Pearson等级相关系数分析CT参数与mPAP、PVR的相关性。结果:两组间差异有统计学意义的CT指标有MPAD、RPAD、LPAD、RLPAD、RVD、脊柱室间隔夹角、rPA、RVD/LVD、ASD直径,其中RPAD、LPAD、脊柱室间隔夹角、rPA、RVD/LVD、ASD直径对PAH具有中等强度的诊断效能(AUC均>0.7);MPAD、rPA、ASD直径与mPAP呈中度正相关,MPAD、rPA、RVD/LVD与PVR呈中度正相关,ASD直径与PVR呈高度正相关。结论:双源CT对成人ASD合并PAH具有一定的诊断价值,可以为临床治疗前综合评估、长期随访与管理提供较好的依据。
Abstract:Objective: To investigate the diagnostic value of dual-source CT (DSCT) in evaluating adults with atrial septal defect (ASD) with pulmonary hypertension (PAH). Methods: Seventy-five adult patients with ASD in our hospital were retrospectively analyzed. The study sample was divided into 2 groups (PAH group (n=40) and non-PAH group (n=35 cases)) according to the mean pulmonary artery pressure (mPAP) obtained by right cardiac catheterization (RHC) (PAH: ≥ 25 mmHg). All patients were examined for congenital heart disease by DSCT one week before RHC. The ascending aorta diameter (AAD), main pulmonary artery diameter (MPAD), right pulmonary artery diameter (RPAD), left pulmonary artery diameter (LPAD), right lower pulmonary artery diameter (RLPAD), the maximum diameter of the short axis of both the ventricles (RVD, LVD), included the angle of the spinal ventricular septum and ASD diameter, were measured on the image. The MPAD to AAD ratio (rPA) and the RVD to LVD ratio (RVD/LVD) were calculated. Differences between the two groups in terms of clinical data, RHC indexes, and CT cardiovascular parameters were evaluated by a t-test. The ROC curve was used to determine the diagnostic efficacy of DSCT in adults with ASD and PAH. Pearson correlation coefficient was used to analyze the association between the CT parameters, mPAP, and PVR. Results: The statistically significant CT indexes between the two groups were MPAD, RPAD, LPAD, RLPAD, RVD including the angle of the spinal ventricular septum, rPA, RVD/LVD, and ASD diameter. Of these, the RPAD and LPAD including the angle of the spinal ventricular septum, rPA, RVD/LVD, and ASD diameter demonstrated moderate diagnostic efficacy for PAH (AUC>0.7). The MPAD, rPA, and ASD diameter with mPAP were moderately positively correlated. The MPAD, rPA, and RVD/LVD with PVR were also mildly positively correlated. Furthermore, the ASD diameter and PVR were highly positively correlated. Conclusion: DSCT is diagnostically valuable for the evaluation of adults with ASD complicated with PAH. In particular, DSCT may be used to provide a comprehensive evaluation before clinical treatment, as well as for long-term follow-up and management.
-
-
表 1 两组间临床基线资料及RHC指标比较
Table 1 Comparison of clinical baseline data and right heart catheterization indexes between the two groups
项目 组别 P 无PAH组(n=35) PAH组(n=40) 年龄/岁 40.49±16.99 44.68±12.28 0.22 男性/(n,%) 11.00(31.43) 10.00(25.00) 0.54 BSA/m2 1.65±0.11 1.67±0.14 0.59 NYHA分级 <0.05 Ⅰ~Ⅱ级(n,%) 35.00(100.00) 31.00(77.50) Ⅲ~Ⅳ级(n,%) 0.00(0.00) 9.00(22.50) PASP/mmHg 38.03±12.78 50.85±20.76 <0.05 PADP/mmHg 16.12±6.80 20.98±8.80 <0.05 mPAP/mmHg 17.97±2.75 34.00±11.08 <0.05 PVR(Wood) 1.38±0.67 5.70(3.24~15.12) <0.05 表 2 两组间CT心血管参数测量值比较
Table 2 Comparison of CT cardiovascular parameters between the two groups
心血管参数 组别 P 无PAH组(n=35) PAH组(n=40) AAD 28.91±4.74 28.41±4.81 0.652 MPAD/mm 31.14±6.27 36.34±8.52 <0.05 RPAD/mm 23.66±5.28 27.91±6.23 <0.05 LPAD/mm 23.05±5.24 27.30±5.84 <0.05 RLPAD/mm 14.24±2.78 16.49±3.75 <0.05 RVD/mm 43.22±9.72 48.43±8.75 <0.05 LVD/mm 35.97±5.77 34.87±7.89 0.499 脊柱室间隔夹角/° 51.93±12.83 61.87±11.68 <0.05 rPA 1.08±0.18 1.31±0.38 <0.05 RVD/LVD 1.21±0.24 1.43±0.29 <0.05 ASD直径/mm 17.28±4.43 24.95±5.32 <0.05 表 3 CT心血管参数预测PAH的ROC曲线分析
Table 3 ROC curve analysis of CT cardiovascular parameters predicting PAH
心血管参数 AUC值(95%CI) P 截断值 敏感度/% 特异度/% 约登指数 MPAD/mm 0.68(0.55~0.80) <0.05 35.00 0.58 0.74 0.32 RPAD/mm 0.71(0.59~0.83) <0.05 21.95 0.88 0.51 0.39 LPAD/mm 0.72(0.60~0.83) <0.05 23.50 0.80 0.60 0.40 RLPAD/mm 0.68(0.56~0.81) <0.05 16.95 0.45 0.91 0.36 脊柱室间隔夹角/° 0.72(0.61~0.84) <0.05 63.35 0.53 0.86 0.38 rPA 0.70(0.58~0.82) <0.05 1.20 0.63 0.83 0.45 RVD/LVD 0.71(0.59~0.82) <0.05 1.22 0.83 0.51 0.34 ASD直径/mm 0.85(0.77~0.93) <0.05 22.32 0.68 0.89 0.56 表 4 mPAP与CT心血管测量参数相关性分析
Table 4 Correlation analysis of mPAP and CT cardiovascular measurement parameters
心血管参数 r P MPAD/mm 0.51 <0.05 RPAD/mm 0.45 <0.05 LPAD/mm 0.44 <0.05 RLPAD/mm 0.47 <0.05 脊柱室间隔夹角/° 0.36 <0.05 rPA 0.61 <0.05 RVD/LVD 0.47 <0.05 ASD直径/mm 0.62 <0.05 表 5 PVR与CT心血管测量参数相关性分析
Table 5 Correlation analysis of PVR and CT cardiovascular measurement parameters
心血管参数 r P MPAD/mm 0.56 <0.05 RPAD/mm 0.48 <0.05 LPAD/mm 0.47 <0.05 RLPAD/mm 0.44 <0.05 脊柱室间隔夹角/° 0.39 <0.05 rPA 0.63 <0.05 RVD/LVD 0.52 <0.05 ASD直径/mm 0.81 <0.05 表 6 CT心脏参数测量值相关性分析
Table 6 Correlation analysis of CT cardiac parameter measurements
相关系数 RVD LVD RVD/LVD 脊柱室间隔夹角 RVD 1.00 LVD 0.49** 1.00 RVD/LVD 0.45** -0.06 1.00 脊柱室间隔夹角 0.52** -0.47** 0.50** 1.00 注:**-在0.01级别(双尾),相关性显著。 -
[1] BRIDA M, CHESSA M, CELERMAJER D, et al. Atrial sepals defect in adulthood: A new paradigm for congenital heart disease[J]. Europen Heart Journal, 2022, 43(28): 2660−2671. doi: 10.1093/eurheartj/ehab646
[2] MANDRAS S A, MEHTA H S, VAIDYA A. Pulmonary hypertension: A brief guide for clinicians[J]. Mayo Clinic Proceedings, 2020, 95(9): 1978−1988. doi: 10.1016/j.mayocp.2020.04.039
[3] 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志, 2021,101(1): 11−51. doi: 10.3760/cma.j.cn112137-20201008-02778 Group of Pulmonary Embolism and Pulmonary Vascular Disease, Respiratory Branch of Chinese Medical Association, Working Committee of Pulmonary Embolism and Pulmonary Vascular Disease, Respiratory Branch of Chinese Medical Association. Chinese guidelines for diagnosis and treatment of pulmonary hypertension (2021 Edition)[J]. Chinese Medical Journal, 2021, 101(1): 11−51. (in Chinese). doi: 10.3760/cma.j.cn112137-20201008-02778
[4] ENGELFRIET P M, DUFFELS M G, MÖLLER T, et al. Pulmonary arterial hypertension in adults born with a heart septal defect: The euro heart survey on adult congenital heart disease[J]. Heart, 2007, 93(6): 682−687. doi: 10.1136/hrt.2006.098848
[5] 宋会军, 刘琼, 金敬琳, 等. 房间隔缺损大小二维经胸超声心动图、二维及三维CT血管造影测量对比研究[J]. 中国介入心脏病学杂志, 2021,29(6): 318−323. doi: 10.3969/j.issn.1004-8812.2021.06.005 SONG H J, LIU Q, JIN J L, et al. Comparative study of atrial septal defect size by two-dimensional transthoracic echocardiography, two-dimensional and three-dimensional CT angiography[J]. Chinese Journal of Interventional Cardiology, 2021, 29(6): 318−323. (in Chinese). doi: 10.3969/j.issn.1004-8812.2021.06.005
[6] LATSON L, BRISTON D. Atrial septal defect: Transcatheter closure is not bad, but there is more to the story[J]. JACC-Cardiovascular Interventions, 2021, 14(5): 576−577. doi: 10.1016/j.jcin.2021.01.008
[7] ZWIJNENBURH R D, BAGGEN V J M, GEENEN L W, et al. The prevalenceof pulmonary arterial hypertension before and after atrial septaldefect closure at adult age: A systematic review[J]. Amercian Heart Journal, 2018, 201: 63−71. doi: 10.1016/j.ahj.2018.03.020
[8] GALIÈ N, HUMBERT M, VACHIERY J L, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Revista Espanola de Cardiologia (English Edition), 2016, 69(2): 177. doi: 10.1016/j.rec.2016.01.002
[9] KHEIWA A, HARI P, MADABHUSHI P, et al. Patent foramen ovale and atrial septal defect[J]. Echocardiography, 2020, 37(12): 2172−2184. doi: 10.1111/echo.14646
[10] BAUMGARTNER H, de BACKER J, BABU-NARAYAN S V, et al. 2020 ESC guidelines for the management of adult congenital heart disease[J]. Europen Heart Journal, 2021, 42(6): 563−645.
[11] MEYER G M B, SPILIMBERGO F B, ALTMAYER S, et al. Correction to: Multiparametric magnetic resonance imaging in the assessment of pulmonary hypertension: Initial experience of a one-stop study[J]. Lung, 2018, 196(4): 497. doi: 10.1007/s00408-018-0130-x
[12] 张伟, 俞同福, 徐海, 等. CT肺动脉成像对急性肺栓塞患者肺动脉高压严重程度的评估[J]. 放射学实践, 2013,28(3): 324−328. doi: 10.3969/j.issn.1000-0313.2013.03.026 ZHANG W, YU T F, XU H, et al. Assessment of the severity of pulmonary hypertension in patients with acute pulmonary embolism by CT pulmonary artery imaging[J]. Radiological Practice, 2013, 28(3): 324−328. (in Chinese). doi: 10.3969/j.issn.1000-0313.2013.03.026
[13] 梁妍, 胡春峰, 程守全, 等. 心脏磁共振成像对左向右分流型先天性心脏病合并肺动脉高压的诊断价值及右心室功能评估[J]. 中国循证心血管医学杂志, 2022,14(1): 79−83, 86. doi: 10.3969/j.issn.1674-4055.2022.01.18 LIANG Y, HU C F, CHENG S Q, et al. Diagnostic value of cardiac magnetic resonance imaging in left to right shunt congenital heart disease with pulmonary hypertension and evaluation of right ventricular function[J]. Chinese Journal of Evidence based Cardiovascular Medicine, 2022, 14(1): 79−83, 86. (in Chinese). doi: 10.3969/j.issn.1674-4055.2022.01.18
[14] 刘敏, 马展鸿, 郭晓娟, 等. 慢性血栓栓塞性肺动脉高压CTPA测定脊柱室间隔角与右室功能、氨基末端脑钠肽前体的关系[J]. 中华医学杂志, 2011,91(41): 2903−2906. doi: 10.3760/cma.j.issn.0376-2491.2011.41.008 LIU M, MA Z H, GUO X J, et al. CTPA determination of the relationship between spinal ventricular septal angle, right ventricular function and N-terminal pro brain natriuretic peptide in chronic thromboembolic pulmonary hypertension[J]. Chinese Medical Journal, 2011, 91(41): 2903−2906. (in Chinese). doi: 10.3760/cma.j.issn.0376-2491.2011.41.008
[15] KAYAWAKE H, AOYAMA A, KINOSHITA H, et al. Diameter of the dilated main pulmonary artery in patients with pulmonary hypertension decreases after lung transplantation[J]. Surgery Today, 2020, 50(3): 275−283. doi: 10.1007/s00595-019-01887-6
[16] CORSON N, ARMATO S G, LABBY Z E, et al. CT-based pulmonary artery measurements for the assessment of pulmonary hypertension[J]. Academic Radiology, 2014, 21(4): 523−530. doi: 10.1016/j.acra.2013.12.015
[17] 周拓. CT肺动脉成像对COPD合并肺动脉高压的诊断价值[J]. 中国CT和MRI杂志, 2019,17(5): 79−82. doi: 10.3969/j.issn.1672-5131.2019.05.024 ZHOU T. Diagnostic value of CT pulmonary artery imaging in COPD with pulmonary hypertension[J]. Chinese Journal of CT and MRI, 2019, 17(5): 79−82. (in Chinese). doi: 10.3969/j.issn.1672-5131.2019.05.024
[18] WU X G, SHI Y J, WANG X H, et al. Diagnostic value of computed tomography-based pulmonary artery to aorta ratio measurement in chronic obstructive pulmonary disease with pulmonary hypertension: A systematic review and meta-analysis[J]. Clinical Respiratory Journal, 2022, 16(4): 276−283. doi: 10.1111/crj.13485
[19] CARO-DOMÍNGUEZ P, COMPTON G, HUMPL T, et al. Pulmonary arterial hypertension in children: Diagnosis using ratio of main pulmonary artery to ascending aorta diameter as determined by multi-detector computed tomography[J]. Pediatric Radiology, 2016, 46(10): 1378−1383. doi: 10.1007/s00247-016-3636-5
[20] TRUONG Q A, MASSARO J M, ROGERS I S, et al. Reference values for normal pulmonary artery dimensions by noncontract cardiac computed tomography: The framingham heart study[J]. Circulation Cardiovascular Imaging, 2012, 5(1): 147−154. doi: 10.1161/CIRCIMAGING.111.968610
[21] LIANG H W, ZHAO D L, LIU X D, et al. ECG-gated pulmonary artery CTA for evaluation of right ventricular function in patients with acute pulmonary embolism[J]. Echocardiography, 2017, 34(2): 257−263. doi: 10.1111/echo.13419
[22] LI D, TANG X, ZHU Y, et al. Pulmonary artery size measurements: A comparison study between electrocardiogram-gated and nonelectrocardiogram-gated computed tomography[J]. Journal of Computer Assisted Tomography, 2021, 45(3): 415−420. doi: 10.1097/RCT.0000000000001144